ACA
Overvalued by 19.8% based on the discounted cash flow analysis.
Market cap | $5.28 Billion |
---|---|
Enterprise Value | $5.77 Billion |
Dividend Yield | $0.2 (0.184586986617443%) |
Earnings per Share | $3.27 |
Beta | 0.71 |
Outstanding Shares | 48,700,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 41.06 |
---|---|
PEG | -77.13 |
Price to Sales | 2.13 |
Price to Book Ratio | 2.05 |
Enterprise Value to Revenue | 2.32 |
Enterprise Value to EBIT | 41.57 |
Enterprise Value to Net Income | 44 |
Total Debt to Enterprise | 0.21 |
Debt to Equity | 0.48 |
No data
No data